Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Haleh Rezaee"'
Autor:
Naser Aslanabadi, Elnaz Khani, Sajad Khiali, Haleh Rezaee, Saba Pishdad, Taher Entezari-Maleki
Publikováno v:
Pharmaceutical Sciences, Vol 30, Iss 1, Pp 129-134 (2024)
Background: Periprocedural myocardial injury (PMI) after percutaneous coronary intervention (PCI) is a substantial health issue with a high mortality rate. Inflammation and oxidative stress are major contributing factors to PMI. Allopurinol inhibits
Externí odkaz:
https://doaj.org/article/5b673c97321949f5ad16b3ccfeedf423
Publikováno v:
Pharmacology Research & Perspectives, Vol 10, Iss 1, Pp n/a-n/a (2022)
Abstract The novel coronavirus disease 2019 (COVID‐19) emerged in late December 2019 in china and has rapidly spread to many countries around the world. The effective pharmacotherapy can reduce the mortality of COVID‐19. Antiviral medications are
Externí odkaz:
https://doaj.org/article/db2a3470ca454ae595568872c4173b6f
Publikováno v:
Journal of Pharmaceutical Care, Pp 70-74 (2020)
Background: Drug utilization review is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. Vancomycin is a narrow-spectrum glycopeptide anti-infective with activity against many gram-positive organis
Externí odkaz:
https://doaj.org/article/da1431ec5ab4416ab7a53d4ee2df76c8
Autor:
Homa Rezaei, Sajad Khiali, Hadis Rezaei, Haleh Rezaee, Hossein Bannazadeh Baghi, Matin Pourghasem, Taher Entezari-Maleki
Publikováno v:
Pharmaceutical Sciences, Vol 27, Iss Covid-19, Pp S29-S49 (2021)
The coronavirus disease 2019 (COVID-19) outbreak has caused a public health crisis worldwide. However, data regarding the protective factors of the disease is limited. Consequently, preventive health measures that can decrease the risk of infection,
Externí odkaz:
https://doaj.org/article/15045a88011f4b13ba3797f32efc4ef6
Publikováno v:
Journal of Pharmaceutical Care, Pp 93-95 (2020)
Abstract Background: Epiploic appendagitis is natural fats at the anti-mesenchymal surface of the colon. EP is self- limited. Misdiagnosis can lead to unnecessary hospitalization, antibiotic therapy, and surgical intervention. The incidence report
Externí odkaz:
https://doaj.org/article/3768346d13d845a6a577ece143ad2373
Autor:
Parviz Saleh, Hadi Hamishekar, Farnaz Naeimzadeh, Sara Mikaili, Hamid Owaysee Osquee, Haleh Rezaee
Publikováno v:
Journal of Pharmaceutical Care, Vol 7, Iss 1-2, Pp 21-25 (2019)
Background: The inappropriate use of antibiotic leads to microbial resistance, nosocomial infections and increased hospital costs. The broad-spectrum antibiotics, such as cefepime and piperacillin/tazobactam play an important role in the empiric ther
Externí odkaz:
https://doaj.org/article/f9ad0102a49c49429dee7b97b15efc90
Autor:
Kamal Boostani, Hamid Noshad, Farahnoosh Farnood, Haleh Rezaee, Soheil Teimouri, Taher Entezari-Maleki, Reyhane Najafiazar, Azam Hassanpouri-Olia, Afshin Gharekhani
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 9, Iss 1, Pp 174-179 (2019)
Introduction: Medication errors (MEs) are a leading cause of morbidity and mortality, yet they have remained as confusing and underappreciated concept. The complex pharmacotherapy in hospitalized patients and sometimes serious clinical consequences o
Externí odkaz:
https://doaj.org/article/1738a131dd0343568f20e457530867f3
Autor:
Haleh Rezaee, Fariba Pourkarim, Samira Pourtaghi‐Anvarian, Taher Entezari‐Maleki, Touraj Asvadi‐Kermani, Masoud Nouri‐Vaskeh
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 1, Pp n/a-n/a (2021)
Abstract Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the concomitant use of multiple drugs. DDI may occur in patients under treatment with medications used for coronavirus disease 2019 (COVID‐19; i.e.
Externí odkaz:
https://doaj.org/article/e35737d5c30e412ca6b8bbcfa25d13d5
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 10, Iss 4, Pp 488-489 (2020)
Externí odkaz:
https://doaj.org/article/11caf39a068a41d8ab564597a9000f29
Publikováno v:
Journal of Pharmaceutical Care, Vol 6, Iss 1-2 (2018)
Background: Carbapenems are beta-lactam antibiotics with broad-spectrum activity for Gram-positive, Gram-negative and anaerobic bacteria and have become the antibiotics of last resort for many serious bacterial infections. The irrational use of carba
Externí odkaz:
https://doaj.org/article/7cb0b5af928b42fbaa2edcf3282b2e87